Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)

Tonghua Dongbao Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	332.83	1,104	788.06	865.04	593.38	368.01
Short-Term Investments	-	-	-	-	-	202.74
Trading Asset Securities	40	55.52	58.46	37	150.37	-
Cash & Short-Term Investments	372.83	1,160	846.52	902.04	743.74	570.75
Cash Growth	-47.99%	37.00%	-6.15%	21.28%	30.31%	-15.94%
Accounts Receivable	674.29	869.74	455.99	650.94	571.27	642.44
Other Receivables	8.46	8.79	20.56	7.63	18.05	54.64
Receivables	682.75	878.53	476.55	658.57	589.32	697.09
Inventory	773.63	705.35	653.9	537.92	537.58	628.76
Prepaid Expenses	-	-	0.02	0.03	0.57	-
Other Current Assets	128.75	72.76	79.43	63.9	51.2	30.04
Total Current Assets	1,958	2,816	2,056	2,162	1,922	1,927
Property, Plant & Equipment	2,686	2,671	2,678	2,392	2,288	2,111
Long-Term Investments	609.59	435.01	362.49	457.91	461.79	355.77
Other Intangible Assets	619.32	670.02	487.01	389.07	256.32	256.33
Long-Term Deferred Tax Assets	87.38	38.55	46.19	42.41	37.75	37.79
Long-Term Deferred Charges	877.08	690.91	607.25	447.29	357.83	219.42
Other Long-Term Assets	287.69	449.84	513.13	628.85	479.58	442.95
Total Assets	7,125	7,771	6,750	6,520	5,803	5,350
Accounts Payable	116.05	115.9	80.86	75	68.17	69.15
Accrued Expenses	4.38	30.93	11.03	31.74	15.99	19.21
Short-Term Debt	288.26	150	-	-	-	125
Current Income Taxes Payable	12.98	52.46	-	80.45	37.48	34.72
Current Unearned Revenue	18.32	10.48	21.08	7.89	8.17	-
Other Current Liabilities	15.82	160.39	49.08	73.47	78.37	56.77
Total Current Liabilities	455.8	520.16	162.05	268.55	208.18	304.85
Long-Term Debt	204.49	-	2.65	2.65	2.65	2.65
Long-Term Unearned Revenue	26.39	27.51	28.53	28.67	32.91	33.37
Long-Term Deferred Tax Liabilities	7.19	7.41	7.51	-	0.06	0.23
Total Liabilities	693.87	555.08	200.74	299.87	243.8	341.1
Common Stock	1,982	1,994	1,994	2,034	2,034	2,034
Additional Paid-In Capital	527.92	622.56	641.9	1,006	1,034	934.61
Retained Earnings	4,163	4,725	4,053	3,567	2,679	2,157
Treasury Stock	-251.95	-134.83	-150.37	-398.13	-200.49	-133.46
Comprehensive Income & Other	5.28	5.28	6.39	6.94	7.48	8.25
Total Common Equity	6,426	7,211	6,544	6,215	5,554	5,000
Minority Interest	5.02	5.09	5.31	5.35	5.47	8.42
Shareholders' Equity	6,431	7,216	6,550	6,220	5,559	5,009
Total Liabilities & Equity	7,125	7,771	6,750	6,520	5,803	5,350
Total Debt	492.75	150	2.65	2.65	2.65	127.65
Net Cash (Debt)	-119.92	1,010	843.87	899.39	741.09	443.1
Net Cash Growth	-	19.65%	-6.17%	21.36%	67.25%	96.91%
Net Cash Per Share	-0.06	0.51	0.42	0.44	0.37	0.22
Filing Date Shares Outstanding	1,949	1,916	1,984	2,018	2,018	2,018
Total Common Shares Outstanding	1,949	1,916	1,984	2,018	2,018	2,023
Working Capital	1,502	2,296	1,894	1,894	1,714	1,622
Book Value Per Share	3.30	3.76	3.30	3.08	2.75	2.47
Tangible Book Value	5,806	6,541	6,057	5,826	5,298	4,744
Tangible Book Value Per Share	2.98	3.41	3.05	2.89	2.63	2.34
Buildings	-	1,437	1,452	1,305	1,198	1,160
Machinery	-	1,532	1,591	1,301	1,431	1,314
Construction In Progress	-	1,319	1,158	1,203	1,210	1,087

Source: S&P Capital IQ. Standard template. Financial Sources.